Knock-Out Finder
Your selection:
76 Results
| FC0L37 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 39.000 | 39.000 | 2.808 | 34.134% | - | Société Générale | ||
| FC6P8W | Biomarin Pharmaceutical Inc./KO/Put [endlos]/SOC | - | - | put | Biomarin Pharmaceutical Inc. | 61.086 | 61.086 | 18.552 | 3.168% | - | Société Générale | ||
| FC9LWW | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 54.432 | 54.432 | 10.346 | 8.070% | - | Société Générale | ||
| FD1P8L | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 35.872 | 40.200 | 2.540 | 32.106% | - | Société Générale | ||
| FE5W9E | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 41.203 | 46.170 | 3.296 | 22.023% | - | Société Générale | ||
| FG07TY | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 47.901 | 53.380 | 5.280 | 9.846% | - | Société Générale | ||
| FG0DU0 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 48.388 | 48.388 | 5.030 | 18.277% | - | Société Générale | ||
| FG0DU1 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 50.403 | 50.403 | 6.040 | 14.875% | - | Société Générale | ||
| FG0DU2 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 52.417 | 52.417 | 7.724 | 11.473% | - | Société Générale | ||
| FG0DUZ | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 46.374 | 46.374 | 4.293 | 21.680% | - | Société Générale | ||
| FG0W62 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 56.427 | 56.427 | 14.842 | 4.701% | - | Société Générale | ||
| FG1RYU | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 58.419 | 58.419 | 25.970 | 1.336% | - | Société Générale | ||
| FG1VX1 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/SOC | - | - | call | Biomarin Pharmaceutical Inc. | 49.575 | 55.380 | 6.040 | 6.469% | - | Société Générale | ||
| GG0DRZ | Biomarin Pharmaceutical Inc./Faktor/Short [5]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 65.352 | 62.657 | 4.708 | 5.821% | - | Goldman Sachs | ||
| GG4VK6 | Biomarin Pharmaceutical Inc./Faktor/Long [2]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 27.230 | 50.244 | 1.987 | 15.144% | - | Goldman Sachs | ||
| GK8V7F | Biomarin Pharmaceutical Inc./Faktor/Short [2]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 81.690 | 67.977 | 1.963 | 14.806% | - | Goldman Sachs | ||
| GU8SM5 | Biomarin Pharmaceutical Inc./Faktor/Long [10]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 53.199 | 57.337 | 6.403 | 3.164% | - | Goldman Sachs | ||
| GU8WZL | Biomarin Pharmaceutical Inc./Faktor/Long [4]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 44.333 | 54.677 | 3.998 | 7.656% | - | Goldman Sachs | ||
| GU8X1H | Biomarin Pharmaceutical Inc./Faktor/Short [10]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 65.021 | 60.883 | 6.399 | 2.826% | - | Goldman Sachs | ||
| GV6L9A | Biomarin Pharmaceutical Inc./Faktor/Long [5]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 43.568 | 55.563 | 5.021 | 6.159% | - | Goldman Sachs | ||
| GW1DM7 | Biomarin Pharmaceutical Inc./Faktor/Short [4]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 73.888 | 63.543 | 3.845 | 7.318% | - | Goldman Sachs | ||
| GW1GEZ | Biomarin Pharmaceutical Inc./Faktor/Short [3]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 78.813 | 65.021 | - | 9.814% | - | Goldman Sachs | ||
| GW6MFU | Biomarin Pharmaceutical Inc./Faktor/Long [3]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 39.407 | 53.199 | - | 10.152% | - | Goldman Sachs | ||
| GW6ZHR | Biomarin Pharmaceutical Inc./Faktor/Long [15]/GOLDS | - | - | call | Biomarin Pharmaceutical Inc. | 55.169 | 57.928 | - | 2.166% | - | Goldman Sachs | ||
| GW7BXW | Biomarin Pharmaceutical Inc./Faktor/Short [15]/GOLDS | - | - | put | Biomarin Pharmaceutical Inc. | 63.051 | 60.292 | - | 1.828% | - | Goldman Sachs | ||
| LX9Q43 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 30.035 | 30.035 | 2.118 | 42.130% | - | Lang & Schwarz | ||
| LX9Q44 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 32.037 | 32.037 | 2.317 | 38.272% | - | Lang & Schwarz | ||
| LX9Q45 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 34.039 | 34.039 | 2.507 | 34.414% | - | Lang & Schwarz | ||
| LX9Q46 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 36.041 | 36.041 | 2.717 | 30.556% | - | Lang & Schwarz | ||
| LX9Q47 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 38.044 | 38.044 | 3.053 | 26.698% | - | Lang & Schwarz | ||
| LX9Q48 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 40.046 | 40.046 | 3.392 | 22.840% | - | Lang & Schwarz | ||
| LX9Q49 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 42.048 | 42.048 | 3.932 | 18.982% | - | Lang & Schwarz | ||
| LX9Q5A | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 44.051 | 44.051 | 4.474 | 15.124% | - | Lang & Schwarz | ||
| LX9Q5B | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 46.053 | 46.053 | 5.406 | 11.266% | - | Lang & Schwarz | ||
| LX9Q5C | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 48.055 | 48.055 | 6.654 | 7.408% | - | Lang & Schwarz | ||
| LX9Q5D | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 50.058 | 50.058 | 8.371 | 3.550% | - | Lang & Schwarz | ||
| LX9Q61 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 48.046 | 48.046 | 6.680 | 7.426% | - | Lang & Schwarz | ||
| LX9Q6V | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 36.035 | 36.035 | 2.758 | 30.569% | - | Lang & Schwarz | ||
| LX9Q6X | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 40.038 | 40.038 | 3.430 | 22.855% | - | Lang & Schwarz | ||
| LX9Q6Z | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 44.042 | 44.042 | 4.533 | 15.140% | - | Lang & Schwarz | ||
| LX9SD0 | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 52.000 | 52.000 | - | -0.193% | - | Lang & Schwarz | ||
| LX9SHK | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 52.000 | 52.000 | - | -0.193% | - | Lang & Schwarz | ||
| LX9STW | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 52.000 | 52.000 | - | -0.193% | - | Lang & Schwarz | ||
| LX9SYJ | Biomarin Pharmaceutical Inc./KO/Call [endlos]/LuS | - | - | call | Biomarin Pharmaceutical Inc. | 52.000 | 52.000 | - | -0.193% | - | Lang & Schwarz | ||
| MG69UR |  | Biomarin Pharmaceutical Inc./KO/Call [endlos]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 44.598 | 48.170 | 4.041 | 18.645% | - | Morgan Stanley | |
| MJ1B3S | | Biomarin Pharmaceutical Inc./KO/Put [endlos]/MS | - | - | put | Biomarin Pharmaceutical Inc. | 79.457 | 79.457 | 2.847 | 34.195% | - | Morgan Stanley | |
| MJ1BZ9 | | Biomarin Pharmaceutical Inc./Faktor/Long [4]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 44.343 | 44.343 | 3.999 | 25.110% | - | Morgan Stanley | |
| MJ27ZH | | Biomarin Pharmaceutical Inc./KO/Put [endlos]/MS | - | - | put | Biomarin Pharmaceutical Inc. | 80.955 | 74.470 | 2.708 | 25.773% | - | Morgan Stanley | |
| MJ5AYN | | Biomarin Pharmaceutical Inc./KO/Call [endlos]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 46.222 | 46.222 | - | 21.935% | - | Morgan Stanley | |
| MK4BHP | | Biomarin Pharmaceutical Inc./Faktor/Long [3]/MS | - | - | call | Biomarin Pharmaceutical Inc. | 39.416 | 39.416 | 3.003 | 33.431% | - | Morgan Stanley |